<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Both the incidence of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EA) and its precursor, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) is increasing rapidly in the western world </plain></SENT>
<SENT sid="1" pm="."><plain>The progression of BE to EA follows the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence which makes BE the focus of intervention before the development of EA </plain></SENT>
<SENT sid="2" pm="."><plain>Considerations are given on the feasibility of a screening program for the population at risk, followed by surveillance of patients found to have BE on endoscopy </plain></SENT>
<SENT sid="3" pm="."><plain>Potential management options are then stratified based histological findings of various degrees of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>This begins with watchful waiting or surveillance as in the case of BE with no <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (LGD) </plain></SENT>
<SENT sid="5" pm="."><plain>Ablative therapies such as radiofrequency ablation (RFA) can be considered in non-visible high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) </plain></SENT>
<SENT sid="6" pm="."><plain>With visible lesions and intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD) is generally recommended as a treatment and staging technique </plain></SENT>
<SENT sid="7" pm="."><plain>Esophagectomy remains the treatment of choice in EA where there is a high risk of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> such as those with deeper submucosal invasion, lymph-vascular or neural invasion and those of higher <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> grade </plain></SENT>
</text></document>